CG Results Healthcare has advised Novartis on the divestment of its Boucherville, Canada manufacturing facility
- Service: M&A
- Sector: Healthcare
- Sub Sector: Pharma & Biotech, CROs & CMOs
- Engagement Type: Sell Side
Novartis has divested its sterile fill/finish facility located in Boucherville, Canada to Delpharm, a leading contract development and manufacturing organisation with 18 plants in France, Italy, Belgium, Canada, Poland and The Netherlands. The Boucherville plant will allow Delpharm to conduct sterile vial and ampoule manufacturing in North America.
This deal represents CG Results’ 7th deal advising Novartis over the past 2 years.